Clover Health Investments (CLOV) Change in Receivables (2020 - 2026)

Clover Health Investments has reported Change in Receivables for 7 years, with the latest figure at -$21.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables fell 1174.97% year-over-year to -$21.4 million; the trailing twelve-month figure through Mar 2026 stood at $19.9 million (up 165.74% YoY), and the FY2025 full-year result was $43.3 million, up 443.18% from the prior year.
• Change in Receivables for Q1 2026 stood at -$21.4 million, down from $36.9 million in the prior quarter.
• The five-year high for Change in Receivables was $36.9 million in Q4 2025, with the low at -$29.4 million in Q3 2024.
• Historically, Change in Receivables has averaged $1.5 million across 5 years, with a median of $2.0 million in 2025.
• Annual changes were most pronounced in 2022 — Change in Receivables surged 306.9% — and 2023, when it tumbled 2379.85%.
• Clover Health Investments' Change in Receivables stood at $13.8 million in 2022, then slipped by 12.14% to $12.1 million in 2023, then grew by 17.65% to $14.2 million in 2024, then surged by 159.58% to $36.9 million in 2025, then tumbled by 157.93% to -$21.4 million in 2026.
• The last three Change in Receivables figures came in at -$21.4 million (Q1 2026), $36.9 million (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.